Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/171564
T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is an autoimmune condition that commonly causes kidney impairment and can be fatal. The key participation of B-lymphocytes as ANCA producers and neutrophils as target of these antibodies is widely described as the mechanism of endothelial damage in this disease. There has been a rising interest in the role of T-lymphocytes in AAV in recent years. Evidence is strong from animal models, and T-lymphocytes can be found infiltrating kidney tissue and other tissue sites in AAV patients. Furthermore, the different subsets of T-lymphocytes are also key players in the aberrant immune response observed in AAV. Polarization towards a predominant Th1 and Th17 response in the acute phase of the disease has been described, along with a decline in the number of T-regulatory lymphocytes, which, in turn, show functional impairment. Interactions between different T-cell subsets, and between T-cells and neutrophils and B-cells, also enhance the inflammatory response, constituting a complex network. Novel therapies targeting T-cell immunity are emerging in this scenario and may constitute an interesting alternative to conventional therapy in selected patients. This review aims to summarize the available evidence regarding T-cell imbalances and functional impairment, especially focusing on renal involvement of AAV.
Matèries
Matèries (anglès)
Citació
Citació
MARTINEZ VALENZUELA, Laura, DRAIBE, Juliana, FULLADOSA, Xavier, BESTARD MATAMOROS, Oriol, CRUZADO, Josep ma., TORRAS AMBRÒS, Joan. T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach. _Clinical Kidney Journal_. 2019. Vol. 12, núm. 4, pàgs. 503-511. [consulta: 25 de febrer de 2026]. ISSN: 2048-8505. [Disponible a: https://hdl.handle.net/2445/171564]